• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Measuring Central or Peripheral Blood Pressure Levels? That is the Question in the Modern Clinical Practice of Hypertension.

作者信息

Presta Vivianne, Tocci Giuliano

机构信息

Hypertension Unit, Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sant'Andrea Hospital, University of Rome Sapienza, Rome, Italy.

IRCCS Neuromed, Pozzilli, IS, Italy.

出版信息

High Blood Press Cardiovasc Prev. 2018 Dec;25(4):415-416. doi: 10.1007/s40292-018-0292-x. Epub 2018 Nov 30.

DOI:10.1007/s40292-018-0292-x
PMID:30498940
Abstract
摘要

相似文献

1
Measuring Central or Peripheral Blood Pressure Levels? That is the Question in the Modern Clinical Practice of Hypertension.测量中心血压还是外周血压水平？这是现代高血压临床实践中的问题。
High Blood Press Cardiovasc Prev. 2018 Dec;25(4):415-416. doi: 10.1007/s40292-018-0292-x. Epub 2018 Nov 30.
2
Effect of Amlodipine/Valsartan Versus Nebivolol/Valsartan Fixed Dose Combinations on Peripheral and Central Blood Pressure.氨氯地平/缬沙坦与奈必洛尔/缬沙坦固定剂量组合对外周和中心血压的影响。
High Blood Press Cardiovasc Prev. 2018 Dec;25(4):407-413. doi: 10.1007/s40292-018-0286-8. Epub 2018 Nov 3.
3
Nebivolol/valsartan: Fixed-dose combination for treatment of hypertension.奈必洛尔/缬沙坦：用于治疗高血压的固定剂量复方制剂。
Drugs Today (Barc). 2017 Jan;53(1):19-26. doi: 10.1358/dot.2017.53.1.2560078.
4
Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.比索洛尔和缬沙坦固定剂量复方治疗高血压的疗效和安全性：一项随机、多中心研究。
Lancet. 2014 May 31;383(9932):1889-98. doi: 10.1016/S0140-6736(14)60614-0.
5
Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.氨氯地平/缬沙坦及氨氯地平/缬沙坦/氢氯噻嗪治疗高血压的真实世界临床经验：EXCITE研究
Curr Med Res Opin. 2014 Oct;30(10):1937-45. doi: 10.1185/03007995.2014.942415. Epub 2014 Jul 17.
6
Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension.奈必洛尔与缬沙坦固定剂量联合疗法治疗高血压
Expert Rev Cardiovasc Ther. 2016;14(5):563-72. doi: 10.1586/14779072.2016.1167598. Epub 2016 Apr 7.
7
Trough:peak ratio and smoothness index in the evaluation of 24-h blood pressure control in hypertension: a comparative study between valsartan/hydrochlorothiazide combination and amlodipine.谷峰比值和平滑度指数在评估高血压患者24小时血压控制中的应用：缬沙坦/氢氯噻嗪复方制剂与氨氯地平的比较研究
Eur J Clin Pharmacol. 2002 Jan;57(11):765-70. doi: 10.1007/s00228-001-0393-6.
8
Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.氨氯地平/缬沙坦及氨氯地平/缬沙坦/氢氯噻嗪在高危患者及其他亚组中的真实世界有效性。
Vasc Health Risk Manag. 2015 Jan 21;11:71-8. doi: 10.2147/VHRM.S76599. eCollection 2015.
9
Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.高血压一线单药治疗策略比较：培哚普利/氨氯地平与缬沙坦/氨氯地平对比
J Hypertens. 2015 Feb;33(2):401-11. doi: 10.1097/HJH.0000000000000409.
10
Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study.氨氯地平-缬沙坦联合治疗较氨氯地平-阿替洛尔联合治疗更有效地降低中心收缩压：EXPLOR 研究。
Hypertension. 2010 Jun;55(6):1314-22. doi: 10.1161/HYPERTENSIONAHA.109.148999. Epub 2010 Apr 19.

引用本文的文献

1
Central Blood Pressure Waves Assessment: A Validation Study of Non-invasive Aortic Pressure Measurement in Human Beings.中心血压波评估：人体无创主动脉压测量的验证研究。
High Blood Press Cardiovasc Prev. 2020 Apr;27(2):165-174. doi: 10.1007/s40292-020-00371-4. Epub 2020 Mar 25.

本文引用的文献

1
Effect of Amlodipine/Valsartan Versus Nebivolol/Valsartan Fixed Dose Combinations on Peripheral and Central Blood Pressure.氨氯地平/缬沙坦与奈必洛尔/缬沙坦固定剂量组合对外周和中心血压的影响。
High Blood Press Cardiovasc Prev. 2018 Dec;25(4):407-413. doi: 10.1007/s40292-018-0286-8. Epub 2018 Nov 3.
2
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
3
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
降压预防心血管疾病和死亡：系统评价和荟萃分析。
Lancet. 2016 Mar 5;387(10022):957-967. doi: 10.1016/S0140-6736(15)01225-8. Epub 2015 Dec 24.
4
Central blood pressure, arterial stiffness, and wave reflection: new targets of treatment in essential hypertension.中心血压、动脉僵硬度与波反射：原发性高血压治疗的新靶点
Curr Hypertens Rep. 2009 Jun;11(3):190-6. doi: 10.1007/s11906-009-0034-5.
5
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.降压药物对中心动脉压及临床结局的不同影响：导管动脉功能评估（CAFE）研究的主要结果
Circulation. 2006 Mar 7;113(9):1213-25. doi: 10.1161/CIRCULATIONAHA.105.595496. Epub 2006 Feb 13.
6
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study.在普通人群中，动态血压和家庭血压与诊室血压相比的预后价值：动脉压监测及其关联研究（PAMELA研究）的随访结果
Circulation. 2005 Apr 12;111(14):1777-83. doi: 10.1161/01.CIR.0000160923.04524.5B. Epub 2005 Apr 4.
7
Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study.在弗雷明汉心脏研究中，收缩压、舒张压和脉压作为充血性心力衰竭风险的预测指标。
Ann Intern Med. 2003 Jan 7;138(1):10-6. doi: 10.7326/0003-4819-138-1-200301070-00006.